SPHK1 and Parkinson disease: Inhibition of sphingosine kinase 1 (SphK1), i.e., the enzyme that catalyzes S1P biosynthesis by sphingosine phosphorylation leads to increased α-Syn secretion and apoptosis in human dopaminergic neurons [120], while pharmacological murine models of PD display reduced activity of this enzyme [121].